Nanosonics Crescita futura

Future criteri di controllo 4/6

Nanosonics prevede che gli utili e i ricavi cresceranno rispettivamente di 24% e 8.7% all'anno. Si prevede che l'EPS crescerà di 23.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 11.2% in 3 anni.

Informazioni chiave

24.0%

Tasso di crescita degli utili

23.8%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	16.1%
Tasso di crescita dei ricavi	8.7%
Rendimento futuro del capitale proprio	11.2%
Copertura analitica	Good
Ultimo aggiornamento	12 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

CHIA:NAN - Stime future degli analisti e dati finanziari passati (AUD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2027	227	28	28	36	9
6/30/2026	208	18	19	24	10
6/30/2025	188	13	14	18	10
6/30/2024	170	13	20	23	N/A
3/31/2024	167	14	21	23	N/A
12/31/2023	164	16	22	24	N/A
9/30/2023	165	18	21	24	N/A
6/30/2023	166	20	20	23	N/A
3/31/2023	154	15	15	20	N/A
12/31/2022	141	10	10	16	N/A
9/30/2022	131	7	5	11	N/A
6/30/2022	120	4	0	7	N/A
3/31/2022	120	7	2	7	N/A
12/31/2021	121	11	4	8	N/A
9/30/2021	112	10	5	8	N/A
6/30/2021	103	9	6	7	N/A
3/31/2021	99	7	7	9	N/A
12/31/2020	95	6	8	10	N/A
9/30/2020	97	8	15	16	N/A
6/30/2020	100	10	21	23	N/A
3/31/2020	96	11	16	18	N/A
12/31/2019	92	12	11	13	N/A
9/30/2019	88	13	7	9	N/A
6/30/2019	84	14	3	5	N/A
3/31/2019	78	12	3	6	N/A
12/31/2018	71	11	4	6	N/A
9/30/2018	66	8	5	8	N/A
6/30/2018	61	6	6	9	N/A
3/31/2018	61	6	N/A	11	N/A
12/31/2017	61	6	N/A	13	N/A
9/30/2017	64	16	N/A	15	N/A
6/30/2017	68	26	N/A	16	N/A
3/31/2017	65	26	N/A	16	N/A
12/31/2016	63	25	N/A	16	N/A
9/30/2016	53	13	N/A	10	N/A
6/30/2016	43	0	N/A	3	N/A
3/31/2016	33	-5	N/A	-3	N/A
12/31/2015	23	-10	N/A	-8	N/A
9/30/2015	23	-8	N/A	-5	N/A
6/30/2015	22	-5	N/A	-2	N/A
3/31/2015	24	-2	N/A	0	N/A
12/31/2014	26	2	N/A	2	N/A
9/30/2014	24	0	N/A	0	N/A
6/30/2014	21	-3	N/A	-3	N/A
3/31/2014	21	-3	N/A	-3	N/A
12/31/2013	20	-3	N/A	-3	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di NAN ( 24% all'anno) è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che gli utili di NAN ( 24% all'anno) cresceranno più rapidamente del mercato Australian ( 12.4% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di NAN cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di NAN ( 8.7% all'anno) crescerà più rapidamente del mercato Australian ( 5.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di NAN ( 8.7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di NAN sarà basso tra 3 anni ( 11.2 %).

Nanosonics Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Recent updates

Nanosonics Limited Announces Board Retirements

Nanosonics Limited, Annual General Meeting, Nov 12, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: AU$0.043 (vs AU$0.066 in FY 2023)

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

Independent Non-Executive Director recently sold AU$304k worth of stock

New minor risk - Insider selling

Key Executive recently bought AU$100k worth of stock

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Investor sentiment deteriorates as stock falls 30%

Now 37% undervalued after recent price drop

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023

Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023

Nanosonics Limited, Annual General Meeting, Nov 03, 2023

Full year 2023 earnings released: EPS: AU$0.066 (vs AU$0.012 in FY 2022)

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023

CEO, President recently sold AU$121k worth of stock

Nanosonics Announces Company Secretary Changes

Independent Non-Executive Director recently sold AU$504k worth of stock

First half 2023 earnings released

Nanosonics Limited to Report First Half, 2023 Results on Feb 23, 2023

Insufficient new directors

Insufficient new directors

Now 20% undervalued

CEO, President recently sold AU$960k worth of stock

Full year 2022 earnings released: EPS: AU$0.012 (vs AU$0.029 in FY 2021)

Nanosonics Limited, Annual General Meeting, Nov 18, 2022

Nanosonics Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Now 21% undervalued after recent price drop

Nanosonics Limited Announces Management Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Nanosonics Limited to Report First Half, 2022 Results on Feb 22, 2022

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.034 in FY 2020)

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics to Launch Digital Platform for Infection Control

First half 2021 earnings released: EPS AU$0.005 (vs AU$0.019 in 1H 2020)

Revenue misses expectations

New 90-day low: AU$6.41

Nanosonics Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$7.85

New 90-day high: AU$6.72

I-MED Signs Agreement with Nanosonics to Upgrade Their Trophon EPR Fleet to Trophon2

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Earnings released

New 90-day low - AU$5.92

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita